Recent Posts

High Court: Reverse-Payment Settlements Are Not Immune From Antitrust Scrutiny
Posted on 17 Jun 2013 by Joan Grossman

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 17 ruled 5-3 that reverse-payment settlements of patent litigation between the holder of a drug patent and potential generic manufacturers of the drug are not necessarily immunized from... Read More